A mere 30% of investing companies in the pharmaceuticals, life sciences and medical technology sector can remember the correct name of the investment promotion agency (IPA) that could help with their deal, according to a survey by Oxford Intelligence. The FDI research and information specialist also revealed that only 20% of investing companies bothered to use an agency when making an investment. These startling facts raise questions about whether companies understand the role of IPAs properly and whether agencies are providing the right kind of service.